[Federal Register Volume 61, Number 168 (Wednesday, August 28, 1996)]
[Notices]
[Pages 44313-44314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-21924]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Vaccine Safety, Subcommittee on Immunization Coverage, Subcommittee on
Future Vaccines, and the Advisory Commission on Childhood Vaccines
(ACCV), Subcommittee on Vaccine Safety: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-1:30 p.m., September 9, 1996. 8:30 a.m.-
12:30 p.m., September 10, 1996.
Place: Hubert H. Humphrey Building, Room 702A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m.
so they can be escorted to the meeting. Entrance to the meeting at
other times during the day cannot be assured.
Purpose: The Committee shall advise and make recommendations to
the Director of the National Vaccine Program on matters related to
the Program responsibilities.
Matters to be Discussed: The Committee will receive reports on
the status of NVAC nominees to replace members whose terms have
ended, status of new exofficio members from the Department of
Agriculture and the Health Care Financing Administration, and a
discussion regarding the addition of liaison representatives to the
Committee; the recruitment status for the Director, National Vaccine
Program Office (NVPO); update alternatives for adverse event
surveillance and funding options; update immunization registry:
confidentiality issues; NVAC endorsement of the immunization
information system confidentiality paper; update philosophical
exemption to immunization; the Measles Vaccine Timing Study--
Discussion of Edmonston-Zagreb (EZ) Vaccine Study; Institutes of
Medicine risk communication safety forum; an update on the
Subcommittee on Immunization Coverage Draft Papers, Thirteen Points
of Leverage to Increase Coverage and Access to Immunization; an
update on the Subcommittee on Future Vaccines, vaccine research
partnership, and a status report on Sabin case studies; an update on
the Subcommittee on Vaccine Safety; update on Adult Immunization
Work Group; report on children's vaccine initiative; update on the
National Vaccine Injury Compensation Program, a report from the Task
Force on Safer Vaccines, a review of adverse events litigation and
compensation in adults; and an update on Acellular Pertussis.
Agenda items are subject to change as priorities dictate.
Name: NVAC Subcommittee on Vaccine Safety and the ACCV,
Subcommittee on Vaccine Safety.
Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This joint ACCV/NVAC subcommittee will review issues
relevant to
[[Page 44314]]
vaccine safety and adverse reactions to vaccines.
Matters to be Discussed: The Subcommittee will discuss the
inclusion of influenza and pneumococcal vaccines in the National
Vaccine Injury Compensation Program summation, direction and
closure; focus of safety subcommittees; and a review of report and
recommendations from the Task Force on Safer Childhood Vaccines.
Name: NVAC Subcommittee on Immunization Coverage.
Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
Place: Hubert H. Humphrey Building, Room 423A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters to be Discussed: The Subcommittee will discuss the forum
on assessment and related immunization issues; the outline for the
Subcommittee's report; and the assessment of immunization coverage.
Name: NVAC Subcommittee on Future Vaccines.
Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will develop policy options and guide
the National Vaccine Program activities which will lead to
development, licensure, and best use of new and existing vaccines in
the simplest possible immunization schedules.
Matters to be Discussed: The Subcommittee will discuss updates
on vaccine procurement strategies, the United States Agency for
International Development vaccine research agenda, and a discussion
of case studies in vaccine development.
Contact Person for More Information: Felecia D. Pearson,
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE,
M/S D50, Atlanta, Georgia 30333, telephone 404/639-7250.
This notice is being published less than 15 days prior to the
meeting due to the inability to transmit the document electronically.
Dated: August 22, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 96-21924 Filed 8-27-96; 8:45 am]
BILLING CODE 4163-18-M